Your shopping cart is currently empty

EGFR kinase inhibitor 3 (compound 2) serves as a dual-action inhibitor targeting both ATP and allosteric sites of the EGFR kinase, exhibiting potent IC50 values of less than 10 nM for wild-type EGFR, 1.5 nM for the L858R mutation, 0.059 nM for the L858R/T790M mutation, and 0.064 nM for the L858R/T790M/C797S mutation. It is classified as a C-linked inhibitor [1].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $2,870 | 3-6 months | 3-6 months | |
| 50 mg | $3,780 | 3-6 months | 3-6 months | |
| 100 mg | $5,200 | 3-6 months | 3-6 months |
| Description | EGFR kinase inhibitor 3 (compound 2) serves as a dual-action inhibitor targeting both ATP and allosteric sites of the EGFR kinase, exhibiting potent IC50 values of less than 10 nM for wild-type EGFR, 1.5 nM for the L858R mutation, 0.059 nM for the L858R/T790M mutation, and 0.064 nM for the L858R/T790M/C797S mutation. It is classified as a C-linked inhibitor [1]. |
| Targets&IC50 | EGFR L858R:1.5 nM, EGFR (WT):<10 nM, EGFR L858R/T790M:0.059 nM, EGFR L858R/T790M/C797S:0.064 nM |
| Molecular Weight | 575.64 |
| Formula | C31H25N7O3S |
| Cas No. | 2922402-03-5 |
| Smiles | S(C)C=1NC(=C(N1)C=2C=C(NC(C)=O)N=CC2)C3=CC(NC(=O)C4=C5C(NC=6C(C(=O)N5)=CC=CC6)=CC=C4)=CC=C3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.